# Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury

> **NCT00004759** · PHASE3 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 497 (—)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** methylprednisolone
- **DRUG:** tirilazad

## Key facts

- **NCT ID:** NCT00004759
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-12
- **Primary completion:** 2007-08
- **Final completion:** —
- **Target enrollment:** 497 (—)
- **Last updated:** 2008-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004759, "Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*